E-visits for isotretinoin management have no effect on interruptions in care
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
|---|---|
| Enthalten in: |
Journal of the American Academy of Dermatology - 88(2023), 3 vom: 11. März, Seite 734-736 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gradwohl, Kelsey [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Continuity of care |
|---|
| Anmerkungen: |
Date Completed 28.02.2023 Date Revised 23.03.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jaad.2022.09.048 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347440088 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347440088 | ||
| 003 | DE-627 | ||
| 005 | 20231226033829.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaad.2022.09.048 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1158.xml |
| 035 | |a (DE-627)NLM347440088 | ||
| 035 | |a (NLM)36228938 | ||
| 035 | |a (PII)S0190-9622(22)02793-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gradwohl, Kelsey |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a E-visits for isotretinoin management have no effect on interruptions in care |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.02.2023 | ||
| 500 | |a Date Revised 23.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a continuity of care | |
| 650 | 4 | |a interruption in care | |
| 650 | 4 | |a isotretinoin | |
| 650 | 4 | |a isotretinoin e-visits | |
| 650 | 4 | |a isotretinoin management | |
| 650 | 4 | |a store-and-forward dermatology | |
| 650 | 4 | |a teledermatology | |
| 650 | 4 | |a telemedicine | |
| 650 | 4 | |a virtual isotretinoin | |
| 650 | 7 | |a Isotretinoin |2 NLM | |
| 650 | 7 | |a EH28UP18IF |2 NLM | |
| 700 | 1 | |a Vaishampayan, Neil |e verfasserin |4 aut | |
| 700 | 1 | |a Eshaq, Milad |e verfasserin |4 aut | |
| 700 | 1 | |a Helfrich, Yolanda |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Academy of Dermatology |d 1984 |g 88(2023), 3 vom: 11. März, Seite 734-736 |w (DE-627)NLM000422703 |x 1097-6787 |7 nnns |
| 773 | 1 | 8 | |g volume:88 |g year:2023 |g number:3 |g day:11 |g month:03 |g pages:734-736 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaad.2022.09.048 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 88 |j 2023 |e 3 |b 11 |c 03 |h 734-736 | ||